Endocannabinoid biochemistry: What do we know after 50 years?

Filomena Fezza, Mauro Maccarrone

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Identification of the active ingredient of cannabis (Δ9-tetrahydrocannabinol, THC) and of its receptor targets has boosted active research into a new field. Indeed, unequivocal evidence for selective sites of action for THC (the so-called cannabinoid receptors) has represented the scaffold for the discovery of a new family of endogenous lipids (the endocannabinoids), that bind to and activate the same sites. Soon after, the enzymes responsible for endocannabinoid biosynthesis and degradation were characterised, along with additional receptor targets and mechanisms of transmembrane transport and intracellular trafficking of these lipids. Altogether endocannabinoids, related receptors and metabolic enzymes form what is known as the endocannabinoid system. In the last 20 years several studies have documented key roles of this system in both animal models of disease and authentic human pathologies, providing the framework for next-generation therapeutic strategies. Current knowledge of the main elements of the endocannabinoid system is reviewed in this chapter, in order to fully appreciate the impact of THC discovery on our understanding of endocannabinoid signalling, a rather complex network that appears critical for both human health and disease.

Original languageEnglish
Title of host publicationCannabinoids
PublisherJohn Wiley and Sons Ltd
Pages53-94
Number of pages42
ISBN (Print)9781118451298, 9781118451298
DOIs
Publication statusPublished - Aug 11 2014

Fingerprint

Endocannabinoids
Biochemistry
Dronabinol
Lipids
Animal Disease Models
Cannabinoid Receptors
Biosynthesis
Complex networks
Pathology
Enzymes
Cannabis
Scaffolds
Animals
Health
Degradation
Research

Keywords

  • Biosynthetic pathways
  • Endocannabinoid system (ECS)
  • Endocannabinoids(eCBs) signalling works
  • Oxidative metabolism
  • Δ9-tetrahydrocannabinol (THC)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Endocannabinoid biochemistry : What do we know after 50 years? / Fezza, Filomena; Maccarrone, Mauro.

Cannabinoids. John Wiley and Sons Ltd, 2014. p. 53-94.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fezza, Filomena ; Maccarrone, Mauro. / Endocannabinoid biochemistry : What do we know after 50 years?. Cannabinoids. John Wiley and Sons Ltd, 2014. pp. 53-94
@inbook{7b38920a7b014590aab9d386b1fb79b0,
title = "Endocannabinoid biochemistry: What do we know after 50 years?",
abstract = "Identification of the active ingredient of cannabis (Δ9-tetrahydrocannabinol, THC) and of its receptor targets has boosted active research into a new field. Indeed, unequivocal evidence for selective sites of action for THC (the so-called cannabinoid receptors) has represented the scaffold for the discovery of a new family of endogenous lipids (the endocannabinoids), that bind to and activate the same sites. Soon after, the enzymes responsible for endocannabinoid biosynthesis and degradation were characterised, along with additional receptor targets and mechanisms of transmembrane transport and intracellular trafficking of these lipids. Altogether endocannabinoids, related receptors and metabolic enzymes form what is known as the endocannabinoid system. In the last 20 years several studies have documented key roles of this system in both animal models of disease and authentic human pathologies, providing the framework for next-generation therapeutic strategies. Current knowledge of the main elements of the endocannabinoid system is reviewed in this chapter, in order to fully appreciate the impact of THC discovery on our understanding of endocannabinoid signalling, a rather complex network that appears critical for both human health and disease.",
keywords = "Biosynthetic pathways, Endocannabinoid system (ECS), Endocannabinoids(eCBs) signalling works, Oxidative metabolism, Δ9-tetrahydrocannabinol (THC)",
author = "Filomena Fezza and Mauro Maccarrone",
year = "2014",
month = "8",
day = "11",
doi = "10.1002/9781118451281.ch3",
language = "English",
isbn = "9781118451298",
pages = "53--94",
booktitle = "Cannabinoids",
publisher = "John Wiley and Sons Ltd",

}

TY - CHAP

T1 - Endocannabinoid biochemistry

T2 - What do we know after 50 years?

AU - Fezza, Filomena

AU - Maccarrone, Mauro

PY - 2014/8/11

Y1 - 2014/8/11

N2 - Identification of the active ingredient of cannabis (Δ9-tetrahydrocannabinol, THC) and of its receptor targets has boosted active research into a new field. Indeed, unequivocal evidence for selective sites of action for THC (the so-called cannabinoid receptors) has represented the scaffold for the discovery of a new family of endogenous lipids (the endocannabinoids), that bind to and activate the same sites. Soon after, the enzymes responsible for endocannabinoid biosynthesis and degradation were characterised, along with additional receptor targets and mechanisms of transmembrane transport and intracellular trafficking of these lipids. Altogether endocannabinoids, related receptors and metabolic enzymes form what is known as the endocannabinoid system. In the last 20 years several studies have documented key roles of this system in both animal models of disease and authentic human pathologies, providing the framework for next-generation therapeutic strategies. Current knowledge of the main elements of the endocannabinoid system is reviewed in this chapter, in order to fully appreciate the impact of THC discovery on our understanding of endocannabinoid signalling, a rather complex network that appears critical for both human health and disease.

AB - Identification of the active ingredient of cannabis (Δ9-tetrahydrocannabinol, THC) and of its receptor targets has boosted active research into a new field. Indeed, unequivocal evidence for selective sites of action for THC (the so-called cannabinoid receptors) has represented the scaffold for the discovery of a new family of endogenous lipids (the endocannabinoids), that bind to and activate the same sites. Soon after, the enzymes responsible for endocannabinoid biosynthesis and degradation were characterised, along with additional receptor targets and mechanisms of transmembrane transport and intracellular trafficking of these lipids. Altogether endocannabinoids, related receptors and metabolic enzymes form what is known as the endocannabinoid system. In the last 20 years several studies have documented key roles of this system in both animal models of disease and authentic human pathologies, providing the framework for next-generation therapeutic strategies. Current knowledge of the main elements of the endocannabinoid system is reviewed in this chapter, in order to fully appreciate the impact of THC discovery on our understanding of endocannabinoid signalling, a rather complex network that appears critical for both human health and disease.

KW - Biosynthetic pathways

KW - Endocannabinoid system (ECS)

KW - Endocannabinoids(eCBs) signalling works

KW - Oxidative metabolism

KW - Δ9-tetrahydrocannabinol (THC)

UR - http://www.scopus.com/inward/record.url?scp=84947550656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947550656&partnerID=8YFLogxK

U2 - 10.1002/9781118451281.ch3

DO - 10.1002/9781118451281.ch3

M3 - Chapter

AN - SCOPUS:84947550656

SN - 9781118451298

SN - 9781118451298

SP - 53

EP - 94

BT - Cannabinoids

PB - John Wiley and Sons Ltd

ER -